Molecular Partners is a clinical-stage biopharmaceutical company based in Switzerland that designs and develops protein therapeutics built on its DARPin platform, a class of small engineered binding proteins. Its pipeline spans treatments for cancer, eye diseases and infectious disease, developed both in-house and with pharmaceutical partners. The company works with collaborators and clinical investigators to advance these candidates through human testing, aiming to offer alternatives to conventional antibody-based medicines.
Molecular Partners AG trades under the code MOLN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #183 of 226 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendWeak
38/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-5.2%
From 52-week high-20.5%
MomentumWeak
45/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-2.8%
6-month return-6.8%
12-month, skipping last month22.2%
Stability (higher is calmer)Weak
25/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)54.3%
Worst drawdown, 1 year (smaller is calmer)-27.6%
LiquidityWeak
19/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.05M CHF
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 2.660 – 3.960Daily closes, split-adjusted
Signals
50-day average3.339
200-day average3.312
Golden/death cross (60d)Golden, 32 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.128
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
3.11
Bullish
EMA 10
3.12
Bullish
SMA 20
3.20
Bearish
EMA 20
3.18
Bearish
SMA 50
3.34
Bearish
EMA 50
3.26
Bearish
SMA 100
3.26
Bearish
EMA 100
3.28
Bearish
SMA 200
3.31
Bearish
EMA 200
3.29
Bearish
Oscillators (daily)
RSI (14)
45.07
Neutral
MACD (12, 26)
-0.08
Bearish
Momentum (12)
-5.71
Bearish
Stochastic %K (14)
47.73
Neutral
Williams %R (14)
-52.27
Neutral
CCI (20)
-77.44
Neutral
Pivot points (classic, last session)
S3
2.87
S2
2.93
S1
3.03
Pivot
3.09
R1
3.19
R2
3.25
R3
3.35
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
